Erythropoietin, Gadolinium, and Nephrogenic Fibrosing Dermopathy

  1. Richard N. Hellman, MD
  1. From Indiana University, Indianapolis, Indiana.

    TO THE EDITOR:

    I read with great interest the article by Swaminathan and colleagues (1) on the possible role of erythropoietin in 22 patients with nephrogenic fibrosing dermopathy. Of interest were the temporal relationship to erythropoietin use, apparent association compared with a control group of higher doses of erythropoietin, and …

    [Full Text of this Article]
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med February 6, 2007 vol. 146 no. 3 229-230
    1. » Excerpt
    2. Full Text
    3. Full Text (PDF)

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. December 1, 2009, 151 (11)
    1. Alert me to current issues